Purdue Pharma Seeks Vote On New $8B Ch. 11 Plan
Close to a year after the U.S. Supreme Court shot down an earlier version of its Chapter 11 plan, OxyContin maker Purdue Pharma was before a New York bankruptcy judge Wednesday...To view the full article, register now.
Already a subscriber? Click here to view full article